AI/ML-enabled medical device firms paid $39.7 million for radiology devices from 2017–2023, raising transparency concerns.
Key Details
- 1AI/ML-enabled medical device developers paid $39.7M for radiology devices over seven years.
- 2Total industry payments to healthcare entities reached $179M in the same period; only cardiovascular devices saw more ($59.4M).
- 3Researchers identified 846 FDA-listed AI/ML-enabled medical devices, but only 79 (9.3%) disclosed payment data.
- 4Annual payments rose from $17.3M in 2017 to $24.6M in 2023, with general payments doubling from $6.6M to $13.3M.
- 5The number of physician and hospital payment recipients more than doubled, but most manufacturers reported no payments.
- 6Study suggests underreporting may occur due to differing device clearance, reimbursement, and classification pathways.
Why It Matters
Financial incentives from AI device manufacturers may influence adoption and promotion decisions in radiology, underlining the importance of transparency. Calls for modernized disclosure requirements could affect radiology-AI industry practices and regulatory oversight.
Source
AuntMinnie
Related News
•AuntMinnie
AI-Enhanced Chest X-rays Improve COPD Mortality Prediction
An open-source AI model using chest x-rays accurately predicts respiratory mortality in COPD patients, outperforming standard clinical risk grading.
•AuntMinnie
AI-CAD Demonstrates High Sensitivity in Breast Cancer Screening
A large study found that AI-based computer-aided detection (AI-CAD) can improve breast cancer detection and support radiologists in screening mammography.
•Radiology Business
Study Compares Popular LLMs for Communicating Radiology Results
Researchers evaluated ChatGPT, Gemini, and Copilot for explaining radiology reports to patients.